ArticleBiomedical optics express2026
Ultrabroadband OCT for simultaneous visible and near-infrared light imaging of the mouse retina.
Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Machine Learning Classification of Retinal Ganglion Cell Dendritic Texture in a 3xTg-Alzheimer's Disease Mouse Model.Diagnostics (Basel, Switzerland) · 2026Article
- Multimodal Optical Biosensing for Precision Medicine and Healthcare: Introduction to the feature issue.Biomedical optics express · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyperspectral optical coherence tomographic imaging of the retina using the visible-near-infrared wavelength range improves the use of spectroscopic information for biomarkers of retinal diseases without compromising the achievable axial resolution. Previous efforts to develop an optical coherence tomograph that covers both visible and near-infrared wavelengths were hampered by the challenges in designing a broadband spectrometer with adequate performance. In this work, we describe an ultrabroadband OCT system we designed that advances the state-of-the art in two major aspects: the design and implementation of a broadband spectrometer employing a 4k-pixel line camera achieving a spectral range of greater than 450nm with a central wavelength of 680nm; and an achromatised imaging system that minimises aberrations in the visible-near-infrared wavelength range for imaging mouse retina. The system provides an axial imaging range greater than 0.67mm within the retina with a larger than 40
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.